基于纳米粒子的mRNA疫苗诱导了保护性中和性抗体,用于在体内感染的传染性支气管炎病毒.
Aseno Sakhrie1, Ankarao Kalluri2, Zeinab H Helal1,3
1Department of Pathobiology, University of Connecticut, Storrs, CT 06269, USA.
Vaccines
|June 27, 2025
概括
新型阴性牛血清专纳米颗粒有效地在中传递传染性支气管炎病毒 (IBV) 尖端蛋白mRNA. 这种mRNA疫苗方法显示了增强的免疫性,为传统IBV疫苗提供了更安全的替代方案.
科学领域:
- 兽医免疫学 兽医免疫学
- 疫苗技术技术 疫苗技术
- 纳米技术纳米技术
背景情况:
- 传统的传染性支气管炎病毒 (IBV) 疫苗面临的局限性包括突变风险和有效性有限.
- 开发更安全,更有效的IBV疫苗对于家禽健康至关重要.
研究的目的:
- 探索性牛血清白蛋白 (BSA) 聚胺纳米颗粒 (NP) 以传递IBV尖端蛋白mRNA.
- 评估这种基于mRNA的系统作为下一代IBV疫苗的潜力.
主要方法:
- 以BSA为基础的NP和具有正表面电荷的NP被合成和特征化 (DLS,Zetasizer,TEM).
- 细胞毒性,细胞吸收和mRNA递送效率在巨细胞系 (HD11) 中进行了评估.
- 免疫原性在无特定病原体 (SPF) 中被评估,测量了抗体标位,中和指数和外周血液单核细胞 (PBMC) 刺激.
主要成果:
- BSA NPs证明了IBV尖端蛋白mRNA的成功结合和高效转移,这种蛋白质被黄素增强.
- 用mRNA载荷NP接种疫苗显著增加了SPF对IBV S蛋白的抗体标位.
- 一次用克洛洛奎因的强剂量使中和指数翻了一番,而PBMC与对照组相比,刺激指数高出三倍.
结论:
- 阴离子BSANP作为IBV尖端蛋白mRNA的有效传递系统.
- 这种mRNA-NP策略增强了免疫反应,为开发更安全,更有效的IBV疫苗提供了有希望的途径.
相关概念视频
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...